Petros Pharmaceuticals Announces Transition from NASDAQ to OTC Markets

The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESSWIRE / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces that it has received a staff determination letter from the […]

Wynk Launches Limited-Edition Mandarin Pomelo, a Bright New Flavor Made for Summer Get-Togethers

Wynk™, the award-winning cannabis seltzer brand, today announced the launch of Mandarin Pomelo, a limited-time summer release crafted to pair perfectly with real-life get-togethers – from backyard BBQs to poolside hangs. https://mma.prnewswire.com/media/2693881/Wynk_MandarinPomeloLTO_THC_MG03.jpg “We’ve seen growing demand for fresh, seasonal flavors that offer something different from our core lineup,” said Angus Rittenburg, CEO of Wynk. “It’s

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron’s $256M 23andMe Acquisition

PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data to aggressively pursue novel drug discovery, biomarker discovery and drug repurposing using AI and machine learning. Earlier this week, Regeneron Pharmaceuticals announced its acquisition

Ocean Power Technologies Completes First Sea Trial for WAM-V(R)s at US Coast Guard Approved Test Site in New Jersey

MONROE TOWNSHIP, N.J., May 22, 2025 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and more productive ocean operations and related power, data, and service solutions, today announced that it has completed its first WAM-V(R)

M2i Global, Inc. Appoints Former White House CISO and Senior Trump Administration Official Camilo Sandoval as Senior Advisor

Brings Executive Insight and Trusted Relationships Across Business, Technology, and Government-Helping Shape AI and Cybersecurity Policy To Drive Government Modernization and Enhance Supply Chain Security. RENO, NV / ACCESSWIRE / May 21, 2025 / M2i Global, Inc. ("M2i," the "Company," "we," "our" or "us") (OTCQB:MTWO), a company specializing in the development and execution of a

Falcon Signs Three-Year Agreement with Toll Group for Hangar and Global Flight Support

DUBAI, United Arab Emirates, May 22, 2025 (GLOBE NEWSWIRE) — Falcon, part of Alex Group Investment, has been selected by Toll Group to provide hangar services in the UAE and worldwide flight support under a three-year agreement related to its government and defence operations. The agreement covers the long-term parking of a Saab 340, a

Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19

CAMBRIDGE, MA / ACCESSWIRE / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA) for mRNA-1083, its flu/COVID combination vaccine candidate for adults aged 50 years and older. The Company plans to resubmit

Arqit Quantum Inc. Announces Financial Results for First Half of Fiscal Year 2025

LONDON, May 22, 2025 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a global leader in quantum-safe encryption, announces financial results for the first half of fiscal year 2025. Consistent with management’s preliminary assessment of the expected range of revenue which was announced 4 April 2025, reported revenue for the first

MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June

TORONTO, May 22, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (“MediPharm” or the “Company“), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the removal of all conditions precedent, related to its previously-announced agreement (the “Purchase Agreement“) for the sale of MediPharm’s facility in Hope, BC, (“Hope Facility“) to Rubicon Organics

Spectral Capital Targets 500 Patents by June 30, 2025

Spectral Capital Corporation (OTCQB: FCCN) today announced it has completed 16 new provisional patent applications, expanding its total patent portfolio to 120. These recent filings – many at the cutting edge of machine learning and quantum computing – reinforce Spectral’s aggressive innovation strategy. The company also unveiled an ambitious goal of reaching 500 patents by

Scroll to Top